Kramer, Victoria
Papazova, Irina
Thoma, Andreas
Kunz, Miriam
Falkai, Peter
Schneider-Axmann, Thomas
Hierundar, Anke
Wagner, Elias
Hasan, Alkomiet
Article History
Received: 1 July 2020
Accepted: 7 August 2020
First Online: 19 August 2020
Compliance with ethical standards
:
: Victoria Kramer, Andreas Thomas, Irina Papazova, Anke Hierundar, Miriam Kunz, Elias Wagner, and Thomas Schneider-Axmann report no conflicts of interest. Peter Falkai was honorary speaker for Janssen-Cilag, Astra-Zeneca, Eli Lilly, Bristol Myers-Squibb, Lundbeck, Pfizer, Bayer Vital, SmithKline Beecham, Wyeth, and Essex. During the last 5 years, he was a member of the advisory boards of Janssen-Cilag, Astra-Zeneca, Eli Lilly, and Lundbeck. Presently, he is a member of the advisory boards of Richter Pharma, Abbot, and Otsuka. Alkomiet Hasan has been invited to scientific meetings by Lundbeck, Janssen, and Pfizer, and he received paid speakerships from Desitin, Janssen, Otsuka, and Lundbeck. He was member of Roche, Otsuka, Lundbeck, and Janssen advisory boards.